HR 1909 reauthorizes federal funding and updates programs to reduce maternal deaths. It requires maternal mortality review committees to include obstetricians/gynecologists and improves death certificate reporting by coordinating with death certifiers. The bill mandates the CDC to share annual best practices for preventing maternal mortality with hospitals, state health groups, and perinatal programs. It also increases annual funding from $58 million to $100 million for these initiatives, covering fiscal years 2025 through 2029. The law directly affects hospitals, state health agencies, and maternal health programs receiving these federal funds.
HR 2730, the Military Moms Act, modifies the TRICARE program to add pregnancy and pregnancy loss (miscarriage or stillbirth) as qualifying life events for enrollment changes, directly affecting military dependents. It requires the Secretary of Defense to issue guidance on documentation for these changes and mandates a detailed report within two years on maternal healthcare access at military facilities and TRICARE network providers, including staffing shortages and travel challenges. The bill also directs the creation of a dedicated Military OneSource webpage with pregnancy resources (excluding abortion information) and requires training for counselors on non-medical pregnancy needs. These provisions aim to improve access to prenatal, birthing, and postpartum care for military families.
HR 679 nullifies specific changes the Food and Drug Administration (FDA) made in January 2023 to the safety rules (REMS) for the abortion pill mifepristone. The bill prohibits the FDA from implementing any future safety rules for mifepristone that are substantially similar to the nullified changes. This directly affects the FDA's regulatory authority over mifepristone, which could impact how healthcare providers prescribe the medication and how patients access it. The bill focuses solely on reversing the FDA's 2023 modifications without altering the drug's broader approval status.
This bill requires providers receiving federal funds to provide detailed, FDA-approved drug warnings about chemical abortions to patients at least 24 hours before the procedure. It mandates that providers highlight warnings and adverse reactions from the drug label, read them to patients, and obtain written confirmation. Non-compliant providers risk losing federal funding, and patients can sue for damages if providers fail to follow these requirements. The law specifically excludes medical emergencies like ectopic pregnancies or miscarriage treatment from its definition of "chemical abortion."
HJRES 144 is a congressional disapproval resolution targeting a specific rule issued by the Department of Veterans Affairs (VA) on December 31, 2025, which addressed "Reproductive Health Services" (90 Fed. Reg. 61310). This resolution directs Congress to disapprove the VA rule under Chapter 8 of Title 5, U.S. Code, meaning the rule would have no legal effect if passed. The bill directly affects the VA's implementation of reproductive health services for veterans, as it seeks to nullify the agency's existing policy. This is a procedural measure, not a substantive policy change, aimed solely at blocking the VA's rule through congressional action.
HR 4074, the Optimizing Postpartum Outcomes Act of 2025, requires the Health and Human Services Secretary to issue guidance within one year on improving Medicaid and CHIP coverage for pelvic health services during pregnancy and the postpartum period (defined as up to 6 months after birth or during lactation). The bill directs the GAO to study coverage gaps for these services and mandates a new CDC-led education campaign to train healthcare providers and inform postpartum women about pelvic floor exams and physical therapy. Key provisions include standardizing terminology for pelvic health conditions, sharing state best practices for payment models, and authorizing $2 million annually for the education program through 2030. This bill directly affects postpartum women covered by Medicaid or CHIP by aiming to increase access to evidence-based pelvic health care.
The BABIES Act (HR 5202) provides federal grants and Medicaid demonstration programs to expand access to freestanding birth centers, primarily benefiting low-risk pregnant women in underserved areas who rely on Medicaid. It allocates $5 million (2026-2030) for grants up to $500,000 per birth center to cover facility upgrades, equipment, and accreditation costs, with priority for centers in maternity care deserts or areas with poor outcomes. Additionally, it creates a 4-year Medicaid demonstration program testing new payment models for birth centers that meet strict standards (like accreditation, licensure, and emergency capabilities), requiring states to develop prospective payment systems covering services from pregnancy through postpartum care. The program aims to improve access and quality of low-risk maternity care while collecting data on clinical outcomes and costs compared to traditional hospital services.
HR 682, the Heartbeat Protection Act of 2025, prohibits physicians from performing abortions without first checking for a detectable fetal heartbeat according to standard medical practice and informing the patient of the results. It directly affects physicians and clinics performing abortions, requiring them to document heartbeat checks and comply with strict exceptions for life-threatening conditions, rape (with 48-hour documentation of counseling/treatment), or incest involving minors (with proof of prior report to authorities). Violations could result in fines or up to five years in prison, though the bill explicitly states it does not create or recognize a right to abortion. The law adds detailed documentation requirements for exceptions and mandates retention of medical records per federal health privacy rules.
HRES 938 is a symbolic House resolution condemning the Supreme Court's 2022 Dobbs decision that overturned Roe v. Wade and Planned Parenthood v. Casey, ending federal abortion rights protection. It commits Congress to advancing reproductive justice through future legislative action and judicial reform to restore public confidence in the Supreme Court. The resolution specifically pledges to protect disproportionately impacted groups, including women of color, undocumented women, low-income women, LGBTQIA+ individuals, and transgender people. As a non-binding resolution, it does not create new law but expresses the House's intent to address the ruling's consequences via constitutional authority.
HR 1289, the Veterans Nutrition and Wellness Act of 2025, creates a 3-year pilot program (the "Food is Medicine" program) within the Department of Veterans Affairs. It provides medically-tailored meals and groceries, along with nutrition education and cooking classes, to veterans enrolled in VA care who have specific chronic conditions (like diabetes, cancer, or heart failure) or maternal health needs (including prenatal/postpartum care with risks like preeclampsia). The program requires VA to partner with community organizations for food sourcing, train VA health providers on integrating the program, and report annually on participant health outcomes, healthcare utilization, and cost savings. The pilot is limited to veterans meeting the defined eligibility criteria and will terminate after three years.
